Literature DB >> 15646795

A curcuminoid and two sesquiterpenoids from Curcuma zedoaria as inhibitors of nitric oxide synthesis in activated macrophages.

Mi Kyung Jang1, Hwa Jin Lee, Ji Sun Kim, Jae-Ha Ryu.   

Abstract

The overproduction of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) is known to be responsible for vasodilation and hypotension observed in septic shock and inflammation. Inhibitors of iNOS, thus, may be useful candidates for the treatment of inflammatory diseases accompanied by overproduction of NO. In the course of screening oriental anti-inflammatory herbs for the inhibitory activity of NO synthesis, a crude methanolic extract of Curcuma zedoaria exhibited significant activity. The activity-guided fractionation and repetitive chromatographic procedures with the EtOAc soluble fraction allowed us to isolate three active compounds. They were identified as 1,7-bis (4-hydroxyphenyl)-1,4,6-heptatrien-3-one (1), procurcumenol (2) and epiprocurcumenol (3) by spectral data analyses. Their concentrations for the 50% inhibition of NO production (IC50) in lipopolysaccharide (LPS)-activated macrophages were 8, 75, 77 microM, respectively. Compound 1 showed the most potent inhibitory activity for NO production in LPS-activated macrophages, while the epimeric isomers, compound 2 and 3 showed weak and similar potency. Inhibition of NO synthesis by compound 1 was very weak when activated macrophages were treated with 1 after iNOS induction. In the immunoblot analysis, compound 1 suppressed the expression of iNOS in a dose-dependent manner. In summary, 1,7-bis (4-hydroxyphenyl)-1,4,6-heptatrien-3-one from Curcuma zedoaria inhibited NO production in LPS-activated macrophages through suppression of iNOS expression. These results imply that the traditional use of C. zedoaria rhizome as anti-inflammatory drug may be explained at least in part, by inhibition of NO production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15646795     DOI: 10.1007/BF02975885

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  4 in total

1.  Cytotoxic constituents from the rhizomes of Curcuma zedoaria.

Authors:  Omer Abdalla Ahmed Hamdi; Syarifah Nur Syed Abdul Rahman; Khalijah Awang; Norhanom Abdul Wahab; Chung Yeng Looi; Noel Francis Thomas; Sri Nurestri Abd Malek
Journal:  ScientificWorldJournal       Date:  2014-07-13

2.  Metabolic Profile Changes of CCl₄-Liver Fibrosis and Inhibitory Effects of Jiaqi Ganxian Granule.

Authors:  Ge Wang; Zehao Li; Hao Li; Lidan Li; Jian Li; Changyuan Yu
Journal:  Molecules       Date:  2016-05-30       Impact factor: 4.411

3.  Roots of Erigeron annuus Attenuate Acute Inflammation as Mediated with the Inhibition of NF- κ B-Associated Nitric Oxide and Prostaglandin E2 production.

Authors:  Mi Jeong Jo; Jong Rok Lee; Il Je Cho; Young Woo Kim; Sang Chan Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-24       Impact factor: 2.629

4.  Hepatic protection and anticancer activity of curcuma: a potential chemopreventive strategy against hepatocellular carcinoma.

Authors:  Yan Li; Xue Shi; Jingwen Zhang; Xiang Zhang; Robert C G Martin
Journal:  Int J Oncol       Date:  2013-11-21       Impact factor: 5.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.